Not in the way the ads suggest. No test sold today can name the psychiatric medication that will work for you, and the FDA has cautioned patients about tests marketed on that promise. What a pharmacogenetic test does show is how your body processes certain medications, which helps a psychiatrist choose a safer starting dose and lean toward or away from drugs that share the same liver enzyme, so it narrows the search rather than settling it.
If you have already been through one or two medications that did nothing, or that hit you hard with side effects on a low dose, the appeal of a test that just hands you the answer is easy to understand. Here is what these tests genuinely do, where they help, and the situations where paying for one changes nothing.
What a pharmacogenetic test actually measures
A pharmacogenetic test, sometimes sold as a DNA test or a genetic test for medication, reads the genes behind the enzymes your liver uses to break medications down. Two of those enzymes, CYP2D6 and CYP2C19, handle a large share of the antidepressants and other psychiatric medications in common use. For each one, your genes place you somewhere on a range: a poor metabolizer who clears the drug slowly, a normal metabolizer, or an ultrarapid metabolizer who clears it fast.
That single fact, how quickly you process a given medication, is the useful thing the test provides. It's a real piece of information. It's also a narrower one than the marketing around these tests implies.
Why it cannot tell you which medication will work
The claim that a test can pick the antidepressant that will lift your depression is where the honest answer parts ways with the sales page. A genetic result describes how your body handles a medication. It does not measure whether that medication will treat your particular depression, anxiety, or mood pattern, and no test on the market has been shown to do that. The FDA has warned the public directly about genetic tests promoted as predicting response to a specific psychiatric drug, because that link has not been established.
What the result reliably supports is dosing, and the choice between drugs that rely on the same enzyme. That is how the published prescribing guidelines use it. A poor metabolizer might start at a lower dose, or move to a medication that leans on a different enzyme. Read that way, the test answers a narrow question well, which makes it one input a psychiatrist weighs alongside everything else he knows about you.
When testing is worth it, and when it changes nothing
Testing earns its cost once a medication has already fallen short. Two patterns bring most people to ask about it: a drug that did nothing at an ordinary dose, and a drug that caused side effects fast at a small one. Your metabolism is a believable part of both stories, and a panel can confirm whether it played a role.
Before a first medication, the picture is different. There the diagnosis and your history carry most of the weight, and a genetic result usually changes very little about what a psychiatrist would prescribe. This is the part the test sellers tend to leave out, and it is the honest core of the answer: a test is worth ordering when the result would change the dose or the drug, and worth skipping when it would not. Knowing that before you pay a laboratory is the point.
Why one medication hit hard and another did nothing
Your metabolizer status often explains experiences that felt baffling at the time. If you clear a medication slowly, a standard dose can build to a higher level in your blood than it was ever meant to reach, which is a common reason side effects arrive fast and hard on a dose that is supposed to be gentle. If you clear it quickly, that same standard dose can pass through before it does much, which is a common reason a medication seems to do nothing at all.
Neither outcome means you failed the medication or it failed you. It can simply mean the dose was wrong for how your body handles that drug, and that's something a result can help correct.
Why your other medications change the reading
A report describes the enzymes you were born with. It has no view of anything else you are taking, and that turns out to matter. Several psychiatric medications are themselves strong brakes on CYP2D6, including paroxetine, fluoxetine, and bupropion. While one of those is in your system, your CYP2D6 activity can drop far enough that your body behaves like a poor metabolizer even though your report reads normal. Pharmacologists call this phenoconversion. The test cannot see it, and it lifts within about a week of stopping the drug that caused it.
This is where a physician's read carries the weight. A result interpreted on its own, without the rest of your medication list in view, can point confidently in the wrong direction, which is why a review of your current medications is often the more useful first step than the test by itself.
Getting the test ordered in Maryland with Ansh Health Associates
At Ansh Health Associates, Dr. Hardik Yadav, MD can order pharmacogenetic testing as part of medication management, over video, for adults anywhere in Maryland. Psychopharmacology is what patients single him out for, and it is what makes a panel worth ordering at all. He is a Board-Certified Psychiatrist with a Master of Public Health and more than 15 years of experience, much of it with severe and complex cases from his work in the corrections system, where a long medication list and overlapping conditions were the rule rather than the exception.
He orders a test when the answer would change what he prescribes or how he doses it, and he will tell you when it would not. A result is read next to your personal and family history, what you have already taken and how your body answered, and how you score on the standard scales he uses: the PHQ-9 for depression, the GAD-7 for anxiety, the ASRS for ADHD, and the MDQ for a mood pattern. He runs the same scale again at follow-up visits, so whether a medication is working becomes a number he can act on rather than a guess. Most patients notice a difference within their first two to four appointments, though that varies from person to person.
Everything happens by video, with no in-person visit required at any stage, and evening and weekend times are open. The platforms are HIPAA-compliant, and because the practice is out-of-network, nothing is filed with an insurer, so your care stays off your insurance record. The 60-minute initial evaluation is $350 and a 30-minute follow-up is $200, paid before the visit, with a superbill provided afterward that you can submit toward out-of-network reimbursement. A free 15-minute consultation is the place to ask whether testing would tell you anything useful in your case, before anything is ordered. If a medication has already fallen short, a full psychiatric evaluation can revisit the diagnosis, the dose, and the history that a genetic result only partly explains.
Common questions
Can a genetic test tell me which antidepressant will work for me?
No test available today can do that, and the FDA has cautioned the public about tests marketed on that promise. What a pharmacogenetic test shows is how quickly your body processes a medication, which guides the dose and the choice between drugs that rely on the same enzyme. Dr. Hardik Yadav, MD, weighs that alongside your history and your measured response, and the prescribing decision is his.
Do I need genetic testing before I start a psychiatric medication?
Usually not. For a first medication, the diagnosis and your history do most of the work. Testing becomes useful once a medication has already fallen short, which is when the result can change what is prescribed or how it is dosed.
Why did a medication give me side effects at a low dose?
One explanation is that you clear that drug slowly, so an ordinary dose reaches a higher level in your blood than intended. A pharmacogenetic test can establish whether that is what happened. Other things can produce the same picture, including another medication you were taking at the time, which is why the result is read in context rather than on its own.
Can I get pharmacogenetic testing in Maryland through telehealth?
Yes. Dr. Yadav can order it as part of medication management for adults anywhere in Maryland, and your visits happen over video. No in-person appointment is required at any stage of care with Ansh Health Associates.